Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib

Title
Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib
Authors
Keywords
-
Journal
Cancer Discovery
Volume 4, Issue 5, Pages 546-553
Publisher
American Association for Cancer Research (AACR)
Online
2014-03-14
DOI
10.1158/2159-8290.cd-13-0353

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now